Overall rank by patents
#24,920
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 6 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
Orasure holds 11 US patents across 6 technology areas, rank #24,920 of 50,000 tracked assignees.
Orasure Technologies, Inc. has been granted 11 US utility patents between 2017 and 2025, placing Orasure Technologies, Inc. at rank #24,920 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.6 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Orasure Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Orasure sits between OMNI Cubed, Inc. (11 patents, rank #24,916) and Osong Medical Innovation Foundation (11 patents, rank #24,924) - the closest US assignees by grant volume. The composite Innovation Score of 42.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 10 grants, compared with 1 in the 2015–2019 window, a +900% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Orasure Technologies, Inc.'s 8.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Orasure Technologies, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
OMNI CUBED, Inc.
11 patents
OMNI LPS. CO., LTD.
11 patents
ONKOS SURGICAL, INC.
11 patents
OPTOMAK, INC.
11 patents
ORBIS WHEELS, INC.
11 patents
ORGANOCLICK AB
11 patents
ORTA DOGU TEKNIK UNIVERSITESI
11 patents
OSONG MEDICAL INNOVATION FOUNDATION
11 patents
ORASURE TECHNOLOGIES, INC.
11 patents
What this shows Orasure holds 11 patents at rank #24,920, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Orasure's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 31% higher than 69% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 9.1% |
| 2023 | 5 | 45.5% |
| 2024 | 2 | 18.2% |
| 2025 | 3 | 27.3% |
Top 6 of 6 technology areas
Overall rank by patents
#24,920
Across all tracked assignees
42.4 out of 100
How to use this portfolio
Orasure's 11 grants land it in the top 31% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.